Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09WVR
|
|||
| Former ID |
DIB000188
|
|||
| Drug Name |
FX-107
|
|||
| Synonyms |
FX-06; FX-06); FX-06HS; FX-06MRI; FX-108; FX-201; IK-600X program; Bbeta(15-42); FX-06 analogs (transplantation), Fibrex Medical; FX-06 analogs (transplantation), Ikaria; Peptide leukocyte migration inhibitor (reperfusion injury/hemorrhagic shock), Ikaria; Peptide leukocyte migration inhibitor (reperfusion injury/hemorrhagic shock), FIBREX Medical R&D; FX-06 analogs (sepsis, septic shock, Dengue), Fibrex Medical
Click to Show/Hide
|
|||
| Indication | Dengue fever [ICD-11: 1D2Z; ICD-10: A97, A97.9; ICD-9: 61] | Preclinical | [1] | |
| Company |
Fibrex Medical R&D GmbH
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fibrin (FG) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023709) | |||
| REF 2 | FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction. Curr Opin Investig Drugs. 2009 Sep;10(9):997-1003. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.